Successful use of extracorporeal membrane oxygenation in severe necrotizing pneumonia caused by Staphylococcus aureus

Pediatric Critical Care Medicine

Volumn 8, Issue 3, 2007, Pages 282-287

  Stroud, Michael H ^a   Okhuysen Cawley, Regina ^a   Jaquiss, Robert ^b   Berlinski, Ariel ^a   Fiser, Richard T ^a  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Activated factor VII; Extracorporeal membrane oxygenation; Extracorporeal membrane oxygenation complications; Necrotizing pneumonia; Panton Valentine leukocidin; Staphylococcus aureus

Indexed keywords

AMINOCAPROIC ACID; ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 7; BRONCHODILATING AGENT; CEFOTAXIME; CEFTRIAXONE; CLINDAMYCIN; HEPARIN; NAFCILLIN; RIFAMPICIN; VANCOMYCIN;

ADOLESCENT; ANESTHESIOLOGICAL TECHNIQUES; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; BLOOD TRANSFUSION; CASE REPORT; CHRONIC RESPIRATORY TRACT DISEASE; CLINICAL FEATURE; COUGHING; DISEASE SEVERITY; DYSPNEA; EMPIRICISM; EXTRACORPOREAL OXYGENATION; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INTENSIVE CARE UNIT; LEUKOPENIA; LUNG COMPLIANCE; MALE; METABOLIC ACIDOSIS; NECROTIZING PNEUMONIA; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULSE OXIMETRY; SCHOOL CHILD; SPIROMETRY; STAPHYLOCOCCUS AUREUS; THORAX RADIOGRAPHY; TREATMENT INDICATION; TREATMENT OUTCOME; WHEEZING;

EID: 34248333783     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000262795.11598.56     Document Type: Article

References (28)

1. Caksen H, Uzum K, Yuksel S: Prognostic factors in children with Staphylococcus aureus sepsis. J Emerg Med 2003; 25:199-201
2. Caksen H, Ozturk MK, Uzum K, et al: Pulmonary complications in patients with staphylococcal sepsis. Pediatr Int 2000; 42:268-271
3. Adem PV, Montgomery CP, Husain AN, et al: Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med 2005; 353:1245-1251
4. ECLS registry report international summary. Ann Arbor, MI, Extracorporeal Life Support Organization, 2006
5. Chambers HF: The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001; 7:178-182
6. Fergie JE, Purcell K: Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children. Pediatr Infect Dis J 2001; 20:860-863
7. Sattler CA, Mason EO Jr, Kaplan SL: Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J 2002; 21:910-917
8. Martinez-Aguilar G, Hammerman WA, Mason EO Jr, et al: Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J 2003; 22:593-598
9. Martinez-Aguilar G, Avalos-Mishaan A, Hulten K, et al: Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J 2004; 23:701-706
10. Kaplan SL, Hulten KG, Gonzalez BE, et al: Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005; 40:1785-1791
11. Frank AL, Marcinak JF, Mangat PD, et al: Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children. Pediatr Infect Dis J 1999; 18:993-1000
12. Lowy FD: Staphylococcus aureus infections. N Engl J Med 1998; 339:520-532
13. Shulman ST, Ayoub EM: Severe staphylococcal sepsis in adolescents. Pediatrics 1976; 58:59-66
14. Centers for Disease Control and Prevention: Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. JAMA 1999; 282:1123-1125
15. Gonzalez BE, Martinez-Aguilar G, Kaplan SL, et al: Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005; 115:642-648
16. Fey PD, Said-Salim B, Rupp ME, et al: Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47:196-203
17. Dufour P, Gillet Y, Bes M, et al: Community-acquired methicillin- resistant Staphylococcus aureus infections in France: Emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002; 35:819-824
18. Gillet Y, Issartel B, Vanhems P, et al: Association between Staphylococcus aureus strains carrying genes for Panton-Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet 2002; 359:753-759
19. Moler FW, Custer JR, Bartlett RH, et al: Extracorporeal life support for severe pediatric respiratory failure: An updated experience 1991-1993. J Pediatr 1994; 124:875-880
20. Vats A, Pettignano R, Culler S, et al: Cost of extracorporeal life support in pediatric patients with acute respiratory failure. Crit Care Med 1998; 26:1587-1592
21. Weber TR, Kountzman B: Extracorporeal membrane oxygenation for non-neonatal pulmonary and multiple-organ failure. J Pediatr Surg 1998; 33:1605-1609
22. Muntean W: Coagulation and anticoagulation in extracorporeal membrane oxygenation. Artif Organs 1999; 23:979-983
23. Atkinson JB, Kitagawa H, Humphries B: Major surgical intervention during extracorporeal membrane oxygenation. J Pediatr Surg 1992; 27:1197-1198
24. Mehta U, Laks H, Sadeghi A, et al: Extracorporeal membrane oxygenation for cardiac support in pediatric patients. Am Surg 2000; 66:879-886
25. Hoffman M, Monroe DM III, Roberts HR: Activated factor VII activates factors IX and X on the surface of activated platelets: Thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis 1998; 9:S61-S65
26. Pychynska-Pokorska M, Moll JM, Krajewski W, et al: The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. Pediatr Crit Care Med 2004; 5:234-239
27. Dominguez TE, Mitchess M, Tabbutt S, et al: Use of recombinant factor VIIa for refractory hemorrhage during extracorporeal membrane oxygenation. Pediatr Crit Care Med 2005; 6:348-351
28. Bui JD, Dexpotis GD, Goodnough LT, et al: Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg 2002; 124:852-854